Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Select Drug Profiles
Select Drug Profiles
,
Payers' Guide
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option
Lynne Lederman, PhD
Read More
Select Drug Profiles
,
Payers' Guide
Eliquis Approved by the FDA to Reduce the Risks of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
Loretta Fala
Read More
Select Drug Profiles
,
Payers' Guide
The Health Burden of Multiple Myeloma: Subcutaneous Velcade a New, Convenient Route of Administration Option
Rhonda Williams, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Kyprolis: A New Treatment Option for Patients with Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib and an Immunomodulatory Agent
Lynne Lederman, PhD, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes
Wayne Kuznar, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome
Alice Goodman, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer
Alice Goodman, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Iclusig: A New Treatment Option for Adults with CML or Ph+ ALL that Is Resistant/ Intolerant to Previous Therapy with TKIs
Lynne Lederman, PhD, Medical Writer
Read More
Select Drug Profiles
,
Payers' Guide
Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients
Loretta Fala
Read More
Select Drug Profiles
,
Payers' Guide
Rayos: A Novel Oral Delayed-Release Prednisone for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
Alice Goodman, Medical Writer
Read More
1
2
3
4
Page 1 of 20
Results 1 - 10 of 200